BeStock  
Stocks › Biotechnology › EWTX

Edgewise Therapeutics EWTX

US equityMarket cap rank #2154Biotechnology
$39.91 −$1.27 (-3.07%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $39.91 0.00%
Open$40.81
Prev close$41.17
Day range$39.71 – $41.41
Volume1.19M
Market cap$4.37B
P/E (TTM)4.8
Dividend yield–

EWTX Stock News

Headlines matching Edgewise Therapeutics or the EWTX ticker, most recent first.

  • Analysts Are Bullish on These Healthcare Stocks: Prime Medicine, Inc. (PRME), Edgewise Therapeutics (EWTX) PositiveTipRanks · 25 Sep 2026 · Direct mention
  • RBC Capital Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $59Market news · 23 Sep 2026 · Direct mention
  • Truist Financial Maintains Edgewise Therapeutics(EWTX.US) With Buy RatingMarket news · 23 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $57Market news · 23 Sep 2026 · Direct mention
  • Wedbush Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Raises Target Price to $53 PositiveMarket news · 23 Sep 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Lexeo Therapeutics, Inc. (LXEO) and Edgewise Therapeutics (EWTX)TipRanks · 23 Sep 2026 · Direct mention
  • H.C. Wainwright Initiates Edgewise Therapeutics(EWTX.US) With Buy Rating, Announces Target Price $57Market news · 21 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $45Market news · 7 Aug 2026 · Direct mention
  • Evercore Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $55Market news · 7 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Raises Target Price to $60 PositiveMarket news · 20 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $60Market news · 20 Aug 2026 · Direct mention
  • Guggenheim Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Raises Target Price to $51 PositiveMarket news · 6 Jul 2026 · Direct mention
  • Evercore Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Raises Target Price to $55 PositiveMarket news · 20 Jul 2026 · Direct mention
  • Oppenheimer Initiates Edgewise Therapeutics(EWTX.US) With Buy Rating, Announces Target Price $51Market news · 10 Jul 2026 · Direct mention
  • J.P. Morgan Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Raises Target Price to $53 PositiveMarket news · 6 Jun 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on EWTX.

Sign in to join the discussion.

Scroll to Top